Leidos stock falls revenue outlook disappoints

What happened

Leidos reported adjusted earnings of $3.62 a share, beating the $3.04 estimate, but revenue of $4.63 billion fell short of the roughly $4.74 billion forecast, and the company lowered its full-year sales outlook.

Confirmed

Global impact / market context

A lower sales outlook means the company expects less money coming in than previously planned. Even though profit per share beat expectations, a reduced forecast can pressure the stock because slower revenue may limit future earnings and cash available for investors.

Analyst inference

The results show a split in government contracting: demand for defense, cybersecurity and intelligence work stays strong, while spending on some federal civilian technology and healthcare programs weakens. Leidos' Health segment revenue fell 12% over the year, offsetting growth elsewhere.

Analyst inference

What to watch

1. Leidos lowered its 2026 revenue guidance to $18 billion to $18.2 billion from $18.2 billion to $18.4 billion, and the new range falls below analysts' consensus estimate of $18.31 billion. Confirmed
2. Watch whether the Health segment's 12% revenue decline continues, since weaker spending on federal civilian technology and healthcare programs could keep offsetting growth in defense and homeland security operations. Analyst inference
3. Watch how quickly Leidos turns its growing backlog of government contracts into revenue, because total backlog rose 4% but questions remain about converting that work into faster sales growth. Analyst inference

Evidence

• seekingalpha.com